StonvexLoading…
StonvexStonvexStonvexCore line items from HELE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Annual 2025 2025-02-28 | Annual 2024 2024-02-29 | Annual 2023 2023-02-28 |
|---|---|---|---|---|
Revenue | $1.79B | $1.91B | $2.01B | $2.07B |
Operating Income | $-782.08M | $142.75M | $260.59M | $211.79M |
Net Income | $-898.98M | $123.75M | $168.59M | $143.27M |
EPS (Diluted) | $-39.08 | $5.37 | $7.03 | $5.95 |
Total Assets | $2.12B | $3.13B | $2.84B | $2.91B |
Total Liabilities | $1.32B | $1.45B | $1.20B | $1.42B |
Cash & Equivalents | $18.89M | $18.87M | $18.50M | $29.07M |
Free Cash Flow OCF − CapEx | $131.91M | $83.14M | $269.42M | $33.38M |
Shares Outstanding | 23.08M | 22.86M | 23.75M | 23.99M |